“The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2”. Cell Death Differ.9 (11): 1240–7. (2002). doi:10.1038/sj.cdd.4401097. PMID12404123.
“Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function”. Mol. Cell17 (3): 393–403. (February 2005). doi:10.1016/j.molcel.2004.12.030. PMID15694340.
“Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death”. Cell80 (2): 285–91. (January 1995). doi:10.1016/0092-8674(95)90411-5. PMID7834748.
“Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis”. Apoptosis6 (5): 319–30. (October 2001). doi:10.1023/A:1011319901057. PMID11483855.
“Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase”. J. Biol. Chem.280 (16): 16045–52. (April 2005). doi:10.1074/jbc.M413488200. PMID15705582.
“BAD partly reverses paclitaxel resistance in human ovarian cancer cells”. Oncogene17 (19): 2419–27. (November 1998). doi:10.1038/sj.onc.1202180. PMID9824152.
“PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition”. Oncogene19 (46): 5291–7. (November 2000). doi:10.1038/sj.onc.1203901. PMID11077446.
“Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members”. Cell Death Differ.6 (6): 525–32. (June 1999). doi:10.1038/sj.cdd.4400519. PMID10381646.
“Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11”. Mol. Endocrinol.11 (12): 1858–67. (November 1997). doi:10.1210/me.11.12.1858. PMID9369453.
“The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2”. Cell Death Differ.9 (11): 1240–7. (2002). doi:10.1038/sj.cdd.4401097. PMID12404123.
“Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function”. Mol. Cell17 (3): 393–403. (February 2005). doi:10.1016/j.molcel.2004.12.030. PMID15694340.
“Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death”. Cell80 (2): 285–91. (January 1995). doi:10.1016/0092-8674(95)90411-5. PMID7834748.
“Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis”. Apoptosis6 (5): 319–30. (October 2001). doi:10.1023/A:1011319901057. PMID11483855.
“Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase”. J. Biol. Chem.280 (16): 16045–52. (April 2005). doi:10.1074/jbc.M413488200. PMID15705582.
“BAD partly reverses paclitaxel resistance in human ovarian cancer cells”. Oncogene17 (19): 2419–27. (November 1998). doi:10.1038/sj.onc.1202180. PMID9824152.
“PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition”. Oncogene19 (46): 5291–7. (November 2000). doi:10.1038/sj.onc.1203901. PMID11077446.
“Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members”. Cell Death Differ.6 (6): 525–32. (June 1999). doi:10.1038/sj.cdd.4400519. PMID10381646.
“Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11”. Mol. Endocrinol.11 (12): 1858–67. (November 1997). doi:10.1210/me.11.12.1858. PMID9369453.